Clinical Trials Directory

Trials / Terminated

TerminatedNCT03227822

Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease

Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease; a Pilot Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Catharina Ziekenhuis Eindhoven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Since the length of lesion seems to be negatively associated with stent patency due to restenosis, it is thought that the efficacy of treatment in patients with multiple (\> 1) short (focal; \> 1 and \< 5 cm) SFA lesions can be improved by spot stenting as compared to the use of one long stent. This study proposes to evaluate the endovascular treatment for patients with SFA lesions by comparing two strategies for patients with extensive occlusive SFA disease; 1) short spot (SS) stenting or 2) long lesion (LL) stenting.

Conditions

Interventions

TypeNameDescription
PROCEDUREShort spot stenting
PROCEDURELong lesion stenting

Timeline

Start date
2013-07-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2017-07-24
Last updated
2018-10-09

Source: ClinicalTrials.gov record NCT03227822. Inclusion in this directory is not an endorsement.